321 related articles for article (PubMed ID: 20408852)
1. Computational design and biological testing of highly cytotoxic colchicine ring A modifications.
Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA
Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852
[TBL] [Abstract][Full Text] [Related]
2. Electrostatic contributions to colchicine binding within tubulin isotypes.
Huzil JT; Barakat K; Tuszynski JA
Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626
[TBL] [Abstract][Full Text] [Related]
3. Computer assisted design of second-generation colchicine derivatives.
Huzil JT; Mane J; Tuszynski JA
Interdiscip Sci; 2010 Jun; 2(2):169-74. PubMed ID: 20640786
[TBL] [Abstract][Full Text] [Related]
4. 2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors.
Chuang HY; Chang JY; Lai MJ; Kuo CC; Lee HY; Hsieh HP; Chen YJ; Chen LT; Pan WY; Liou JP
ChemMedChem; 2011 Mar; 6(3):450-6. PubMed ID: 21360819
[TBL] [Abstract][Full Text] [Related]
5. Free energy calculations on the binding of colchicine and its derivatives with the alpha/beta-tubulin isoforms.
Mane JY; Klobukowski M; Huzil JT; Tuszynski J
J Chem Inf Model; 2008 Sep; 48(9):1824-32. PubMed ID: 18712858
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel anticancer bivalent colchicine-tubulizine hybrids.
Malysheva YB; Combes S; Allegro D; Peyrot V; Knochel P; Gavryushin AE; Fedorov AY
Bioorg Med Chem; 2012 Jul; 20(14):4271-8. PubMed ID: 22739088
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.
Liu T; Dong X; Xue N; Wu R; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Sep; 17(17):6279-85. PubMed ID: 19665898
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
[TBL] [Abstract][Full Text] [Related]
9. [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines.
Mahboobi S; Sellmer A; Höcher H; Eichhorn E; Bär T; Schmidt M; Maier T; Stadlwieser JF; Beckers TL
J Med Chem; 2006 Sep; 49(19):5769-76. PubMed ID: 16970401
[TBL] [Abstract][Full Text] [Related]
10. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
Bhattacharyya B; Panda D; Gupta S; Banerjee M
Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
12. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
[TBL] [Abstract][Full Text] [Related]
13. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
[TBL] [Abstract][Full Text] [Related]
14. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents.
Qian Y; Zhang HJ; Lv PC; Zhu HL
Bioorg Med Chem; 2010 Dec; 18(23):8218-25. PubMed ID: 21036623
[TBL] [Abstract][Full Text] [Related]
16. Naphthylphenstatins as tubulin ligands: synthesis and biological evaluation.
Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem; 2008 Oct; 16(19):8999-9008. PubMed ID: 18790642
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor evaluation of nitrovinyl biphenyls: anticancer agents based on allocolchicines.
Jain N; Yada D; Shaik TB; Vasantha G; Reddy PS; Kalivendi SV; Sreedhar B
ChemMedChem; 2011 May; 6(5):859-68. PubMed ID: 21472861
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents.
Jiang J; Sun B; Wang YY; Cui M; Zhang L; Cui CZ; Wang YF; Liu XG; Lou HX
Bioorg Med Chem; 2012 Apr; 20(7):2382-91. PubMed ID: 22365913
[TBL] [Abstract][Full Text] [Related]
19. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M
J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
